Accurate RX Pharmacy Consulting LLC
Letter data
- Company
- Accurate RX Pharmacy Consulting LLC
- Recipient
- Jeffrey Lyon | General Manager | Accurate RX Pharmacy Consulting LLC | Optum Infusion Services | 15529 College Blvd | Lenexa | , | KS | 66219 | United States
- Issue date
- 2022-06-16
- Posted date
- Not available
- FDA office
- Division of Pharmaceutical Quality Operations III
- Subject
- Not available
- Product
- Drugs
- CMS ID
- 604449
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Accurate RX Pharmacy Consulting LLC
MARCS-CMS 604449 —
June 16, 2022
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Next Day
Product:
Drugs
Recipient:
Recipient Name
Jeffrey Lyon
Recipient Title
General Manager
Accurate RX Pharmacy Consulting LLC
Optum Infusion Services
15529 College Blvd
Lenexa
,
KS
66219
United States
Issuing Office:
Division of Pharmaceutical Quality Operations III
United States
Dear Mr. Lyons:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (WL_604449) issued on September 2, 2020. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Nicholas F. Lyons
Director of Compliance
Division of Pharmaceutical Quality Operations III
Content current as of:
06/22/2022
Regulated Product(s)
Drugs